| HGNC Family | Basic leucine zipper proteins |
| Name | nuclear factor, erythroid 2-like 1 |
| Description | This gene encodes a protein that is involved in globin gene expression in erythrocytes. Confusion has occurred in bibliographic databases due to the shared symbol of NRF1 for this gene, NFE2L1, and for `nuclear respiratory factor 1` which has an official symbol of NRF1. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNFE2L1 (also known as Nrf1 or, in one isoform, TCF11) is a pivotal CNC‐bZIP transcription factor that safeguards cellular proteostasis by mediating the “bounce‐back” response under proteasome inhibition. Synthesized as an endoplasmic reticulum (ER)–bound precursor, NFE2L1 undergoes N-glycosylation, retrotranslocation, and proteolytic processing – events that are tightly regulated by several modulators (including ubiquitin ligases such as Fbw7 and kinases) and activating proteases such as DDI2. These processing events free NFE2L1 from the ER membrane and permit its nuclear entry, where it heterodimerizes with small Maf proteins to induce the transcription of proteasome subunit genes and other stress response factors, thereby reestablishing proteasome activity and ensuring proper protein quality control."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its central role in proteasome homeostasis, NFE2L1 is subject to a variety of post‐translational modifications and regulatory protein interactions that fine-tune its activity. A shorter 65‐kDa isoform can function as a transdominant repressor of Nrf2‐dependent antioxidant gene induction, while NFE2L1’s activity is also modulated by cellular cues such as copper levels. It interacts with kinases (e.g. CK2), deubiquitylases (such as USP15), and enzymes that mediate O-GlcNAcylation (via OGT), which together impact its stability, nuclear accumulation, and transcriptional output. These multifaceted modifications and binding events enable NFE2L1 to respond precisely to diverse proteotoxic, metabolic, and redox stresses."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its proteostatic role, NFE2L1 orchestrates diverse cellular stress responses that transcend protein degradation. Its activity contributes to antioxidant defense and repair mechanisms—in keratinocytes it promotes nucleotide excision repair following UVB insult, while in cardiac and hepatic tissues it supports regenerative and anti‐tumorigenic programs. Moreover, by regulating or interacting with complementary factors (such as USP7, CtBP2, and even counterbalancing Nrf2 or α‐Pal isoforms), NFE2L1 influences cell proliferation, epithelial-to-mesenchymal transition, and even ferroptosis resistance. These multifaceted actions underscore NFE2L1’s significance in maintaining cellular and organ integrity, as well as in modulating cancer cell survival and differentiation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "33"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Cathrine Husberg, Paula Murphy, Elisa Bjørgo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cellular localisation and nuclear export of the human bZIP transcription factor TCF11."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0167-4889(03)00041-7"}], "href": "https://doi.org/10.1016/s0167-4889(03"}, {"type": "t", "text": "00041-7) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12729924"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12729924"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Senthil K Radhakrishnan, Candy S Lee, Patrick Young, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2010.02.029"}], "href": "https://doi.org/10.1016/j.molcel.2010.02.029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20385086"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20385086"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yiguo Zhang, John D Hayes "}, {"type": "b", "children": [{"type": "t", "text": "Identification of topological determinants in the N-terminal domain of transcription factor Nrf1 that control its orientation in the endoplasmic reticulum membrane."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20100471"}], "href": "https://doi.org/10.1042/BJ20100471"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20629635"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20629635"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Janos Steffen, Michael Seeger, Annett Koch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2010.09.012"}], "href": "https://doi.org/10.1016/j.molcel.2010.09.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20932482"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20932482"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Madhurima Biswas, Diane Phan, Momoko Watanabe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.253807"}], "href": "https://doi.org/10.1074/jbc.M111.253807"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21953459"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21953459"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Senthil K Radhakrishnan, Willem den Besten, Raymond J Deshaies "}, {"type": "b", "children": [{"type": "t", "text": "p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.01856"}], "href": "https://doi.org/10.7554/eLife.01856"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24448410"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24448410"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Magdalena Bugno, Mary Daniel, Nikolai L Chepelev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Changing gears in Nrf1 research, from mechanisms of regulation to its role in disease and prevention."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagrm.2015.08.001"}], "href": "https://doi.org/10.1016/j.bbagrm.2015.08.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26254094"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26254094"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Shun Koizumi, Taro Irie, Shoshiro Hirayama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The aspartyl protease DDI2 activates Nrf1 to compensate for proteasome dysfunction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.18357"}], "href": "https://doi.org/10.7554/eLife.18357"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27528193"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27528193"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Tsuyoshi Waku, Hiroyuki Katayama, Miyako Hiraoka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NFE2L1 and NFE2L3 Complementarily Maintain Basal Proteasome Activity in Cancer Cells through CPEB3-Mediated Translational Repression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00010-20"}], "href": "https://doi.org/10.1128/MCB.00010-20"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32366381"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32366381"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Amy Northrop, Holly A Byers, Senthil K Radhakrishnan "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of NRF1, a master transcription factor of proteasome genes: implications for cancer and neurodegeneration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.E20-04-0238"}], "href": "https://doi.org/10.1091/mbc.E20-04-0238"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32924844"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32924844"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Weiping Wang, Annie M Kwok, Jefferson Y Chan "}, {"type": "b", "children": [{"type": "t", "text": "The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M700159200"}], "href": "https://doi.org/10.1074/jbc.M700159200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17609210"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17609210"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Yoshiki Tsuchiya, Hiroaki Taniguchi, Yoshiyuki Ito, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The casein kinase 2-nrf1 axis controls the clearance of ubiquitinated proteins by regulating proteasome gene expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01271-12"}], "href": "https://doi.org/10.1128/MCB.01271-12"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23816881"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23816881"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Min Ok Song, Michael D Mattie, Chang-Ho Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of Nrf1 and Nrf2 in the regulation of copper-responsive transcription."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2014.01.013"}], "href": "https://doi.org/10.1016/j.yexcr.2014.01.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24462598"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24462598"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Michelle A Schultz, Sharika S Hagan, Amrita Datta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nrf1 and Nrf2 transcription factors regulate androgen receptor transactivation in prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0087204"}], "href": "https://doi.org/10.1371/journal.pone.0087204"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24466341"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24466341"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Daniel V Ho, Jefferson Y Chan "}, {"type": "b", "children": [{"type": "t", "text": "Induction of Herpud1 expression by ER stress is regulated by Nrf1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2015.01.026"}], "href": "https://doi.org/10.1016/j.febslet.2015.01.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25637874"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25637874"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jiayu Chen, Xiping Liu, Fenglin Lü, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcription factor Nrf1 is negatively regulated by its O-GlcNAcylation status."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2015.07.030"}], "href": "https://doi.org/10.1016/j.febslet.2015.07.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26231763"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26231763"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Yiguo Zhang, Shaojun Li, Yuancai Xiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The selective post-translational processing of transcription factor Nrf1 yields distinct isoforms that dictate its ability to differentially regulate gene expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep12983"}], "href": "https://doi.org/10.1038/srep12983"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26268886"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26268886"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Kousuke Fukagai, Tsuyoshi Waku, A M Masudul Azad Chowdhury, et al. "}, {"type": "b", "children": [{"type": "t", "text": "USP15 stabilizes the transcription factor Nrf1 in the nucleus, promoting the proteasome gene expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2016.07.045"}], "href": "https://doi.org/10.1016/j.bbrc.2016.07.045"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27416755"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27416755"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Esa Kari, Hanna-Riikka Teppo, Kirsi-Maria Haapasaari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Pathol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jclinpath-2018-205584"}], "href": "https://doi.org/10.1136/jclinpath-2018-205584"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30755497"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30755497"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Meng Wang, Lu Qiu, Xufang Ru, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct isoforms of Nrf1 diversely regulate different subsets of its cognate target genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-019-39536-0"}], "href": "https://doi.org/10.1038/s41598-019-39536-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30814566"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30814566"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Diane H Oh, Diamanda Rigas, Ara Cho, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deficiency in the nuclear-related factor erythroid 2 transcription factor (Nrf1) leads to genetic instability."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/febs.12005"}], "href": "https://doi.org/10.1111/febs.12005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22971132"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22971132"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Anwesha Chatterjee, Amruta Ronghe, Bhupendra Singh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Natural antioxidants exhibit chemopreventive characteristics through the regulation of CNC b-Zip transcription factors in estrogen-induced breast carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biochem Mol Toxicol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jbt.21594"}], "href": "https://doi.org/10.1002/jbt.21594"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25130429"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25130429"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Yonggang Ren, Lu Qiu, Fenglin Lü, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TALENs-directed knockout of the full-length transcription factor Nrf1α that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep23775"}], "href": "https://doi.org/10.1038/srep23775"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27065079"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27065079"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Shuwei Zhang, Yangxu Deng, Yuancai Xiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Synergism and Antagonism of Two Distinct, but Confused, Nrf1 Factors in Integral Regulation of the Nuclear-to-Mitochondrial Respiratory and Antioxidant Transcription Networks."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oxid Med Cell Longev (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2020/5097109"}], "href": "https://doi.org/10.1155/2020/5097109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33376579"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33376579"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "John J W Han, Daniel V Ho, Hyun M Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The deubiquitinating enzyme USP7 regulates the transcription factor Nrf1 by modulating its stability in response to toxic metal exposure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jbc.2021.100732"}], "href": "https://doi.org/10.1016/j.jbc.2021.100732"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33933455"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33933455"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Kenta Kainoh, Ryo Takano, Motohiro Sekiya, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CtBP2 confers protection against oxidative stress through interactions with NRF1 and NRF2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2021.05.069"}], "href": "https://doi.org/10.1016/j.bbrc.2021.05.069"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34052660"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34052660"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Miao Cui, Ayhan Atmanli, Maria Gabriela Morales, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nrf1 promotes heart regeneration and repair by regulating proteostasis and redox balance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-021-25653-w"}], "href": "https://doi.org/10.1038/s41467-021-25653-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34489413"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34489413"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Lu Qiu, Haoming Ning, Yaqian Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Feedback regulation of antioxidant transcription factor NFE2L1 and immunostimulatory factor 41BBL mediates the crosstalk between oxidative stress and tumor immunity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Immunol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molimm.2021.12.001"}], "href": "https://doi.org/10.1016/j.molimm.2021.12.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34902807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34902807"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Sixiao Zhang, Jian Luo, Shuai Zeng "}, {"type": "b", "children": [{"type": "t", "text": "Circ-LRP1B functions as a competing endogenous RNA to regulate proliferation, apoptosis and oxidative stress of LPS-induced human C28/I2 chondrocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Bioenerg Biomembr (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10863-022-09932-9"}], "href": "https://doi.org/10.1007/s10863-022-09932-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35274224"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35274224"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Magdalena Oroń, Marcin Grochowski, Akanksha Jaiswar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The molecular network of the proteasome machinery inhibition response is orchestrated by HSP70, revealing vulnerabilities in cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2022.111428"}], "href": "https://doi.org/10.1016/j.celrep.2022.111428"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36170818"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36170818"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Xingzhu Liu, Chang Xu, Wanglong Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Unravelling the role of NFE2L1 in stress responses and related diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Redox Biol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.redox.2023.102819"}], "href": "https://doi.org/10.1016/j.redox.2023.102819"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37473701"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37473701"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Atsushi Hatanaka, Sota Nakada, Gen Matsumoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The transcription factor NRF1 (NFE2L1) activates aggrephagy by inducing p62 and GABARAPL1 after proteasome inhibition to maintain proteostasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-023-41492-9"}], "href": "https://doi.org/10.1038/s41598-023-41492-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37658135"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37658135"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Meixia Zhang, Zhonghou Wang, Guang Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NFE2L1 restrains ferroptosis by transcriptionally regulating HJURP and participates in the progress of oral squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Bioenerg Biomembr (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10863-023-09987-2"}], "href": "https://doi.org/10.1007/s10863-023-09987-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37848756"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37848756"}]}]}]}
|
| Synonyms | LCR-F1, TCF11, NRF1 |
| Proteins | NF2L1_HUMAN |
| NCBI Gene ID | 4779 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NFE2L1 has 10,269 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 122 datasets.
Click the + buttons to view associations for NFE2L1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NFE2L1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of NFE2L1 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NFE2L1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of NFE2L1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of NFE2L1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NFE2L1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of NFE2L1 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NFE2L1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NFE2L1 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of NFE2L1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of NFE2L1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of NFE2L1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with NFE2L1 protein from the CCLE Cell Line Proteomics dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NFE2L1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of NFE2L1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of NFE2L1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NFE2L1 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing NFE2L1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with NFE2L1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with NFE2L1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of NFE2L1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with NFE2L1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with NFE2L1 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with NFE2L1 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with NFE2L1 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of NFE2L1 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by NFE2L1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with NFE2L1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with NFE2L1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with NFE2L1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with NFE2L1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with NFE2L1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with NFE2L1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for NFE2L1 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NFE2L1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NFE2L1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of NFE2L1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing NFE2L1 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with NFE2L1 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with NFE2L1 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of NFE2L1 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with NFE2L1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing NFE2L1 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of NFE2L1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NFE2L1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of NFE2L1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NFE2L1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of NFE2L1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of NFE2L1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding NFE2L1 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving NFE2L1 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving NFE2L1 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving NFE2L1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing NFE2L1 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing NFE2L1 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing NFE2L1 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by NFE2L1 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by NFE2L1 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by NFE2L1 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of NFE2L1 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of NFE2L1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of NFE2L1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NFE2L1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of NFE2L1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with NFE2L1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with NFE2L1 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with NFE2L1 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of NFE2L1 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for NFE2L1 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of NFE2L1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of NFE2L1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of NFE2L1 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NFE2L1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for NFE2L1 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with NFE2L1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for NFE2L1 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of NFE2L1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of NFE2L1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of NFE2L1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate NFE2L1 protein from the curated KEA Substrates of Kinases dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of NFE2L1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of NFE2L1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with NFE2L1 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of NFE2L1 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of NFE2L1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of NFE2L1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NFE2L1 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain NFE2L1 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by NFE2L1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting NFE2L1 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of NFE2L1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of NFE2L1 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by NFE2L1 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of NFE2L1 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of NFE2L1 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing NFE2L1 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for NFE2L1 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NFE2L1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of NFE2L1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving NFE2L1 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving NFE2L1 protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with NFE2L1 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate NFE2L1 protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NFE2L1 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NFE2L1 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NFE2L1 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of NFE2L1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NFE2L1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NFE2L1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of NFE2L1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of NFE2L1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of NFE2L1 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of NFE2L1 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of NFE2L1 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of NFE2L1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of NFE2L1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of NFE2L1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NFE2L1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of NFE2L1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NFE2L1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with NFE2L1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with NFE2L1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |